Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.92
+1.06 (9.76%)
At close: Sep 26, 2025, 4:00 PM EDT
11.42
-0.50 (-4.19%)
After-hours: Sep 26, 2025, 7:33 PM EDT
Contineum Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$22.20
Upside
+86.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $20 | Buy | Initiates | $20 | +67.79% | Sep 25, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +76.17% | Aug 18, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +67.79% | May 19, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +160.07% | May 15, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +92.95% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +109.73% | Mar 7, 2025 |
| Baird | Baird | Buy Maintains $32 → $16 | Buy | Maintains | $32 → $16 | +34.23% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +160.07% | Jan 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $31 | Buy | Maintains | $32 → $31 | +160.07% | Nov 7, 2024 |
| Baird | Baird | Buy Initiates $32 | Buy | Initiates | $32 | +168.46% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +168.46% | Aug 14, 2024 |
| Stifel | Stifel | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +143.29% | Apr 30, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $30 | Buy | Initiates | $30 | +151.68% | Apr 30, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $25 | Buy | Initiates | $25 | +109.73% | Apr 30, 2024 |